Profile data is unavailable for this security.
About the company
Illumina, Inc. (Illumina) is a provider of sequencing- and array-based solutions for genetic analysis. The Company operates through two segments: Core Illumina and the consolidated variable interest entities (VIEs), which include the activities of GRAIL, Inc. (GRAIL) and Helix Holdings I, LLC (Helix). Core Illumina consists of its core operations. Core Illumina's products and services serve customers in the research, clinical and applied markets, and enable the adoption of a range of genomic solutions. The Company's portfolio of integrated systems, consumables and analysis tools addresses the range of genomic complexity, price points, and throughput, enabling customers to select the solution for their research or clinical challenge. The Company provides reproductive-health solutions, including noninvasive prenatal testing (NIPT), preimplantation genetic screening and diagnosis, and neonatal and genetic health testing.
- Revenue in USD (TTM)3.46bn
- Net income in USD973.00m
- Incorporated2000
- Employees7.30k
- LocationIllumina Inc5200 Illumina WaySAN DIEGO 92122-4616United StatesUSA
- Phone+1 (858) 202-4500
- Fax+1 (858) 202-4766
- Websitehttps://www.illumina.com
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cognex Corporation | 749.14m | 179.98m | 9.87bn | 2.12k | 56.22 | 7.96 | 48.44 | 13.17 | 1.03 | 0.964 | 4.27 | 7.25 | 0.5518 | 2.48 | 5.59 | 352,703.40 | 13.26 | 17.54 | 14.27 | 19.01 | 73.61 | 75.80 | 24.03 | 29.65 | 6.90 | -- | 0.00 | 11.79 | 5.25 | 21.25 | -20.76 | 27.94 | 22.62 | 46.41 |
| Avantor Inc | 5.99bn | -484.50m | 10.69bn | 12.00k | -- | 7.90 | 32.43 | 1.78 | -0.9077 | -0.9629 | 10.97 | 4.12 | 0.6026 | 5.91 | 6.23 | 499,183.30 | -0.5694 | -- | -0.6364 | -- | 31.27 | -- | -0.9449 | -- | 1.21 | 1.26 | 0.6853 | -- | 370.12 | -- | -13.43 | -- | -- | -- |
| PerkinElmer, Inc. | 2.83bn | 232.50m | 11.09bn | 12.50k | 47.86 | 4.10 | 25.38 | 3.91 | 2.08 | 2.10 | 25.42 | 24.37 | 0.459 | 3.91 | 4.73 | 226,762.10 | 3.76 | 4.51 | 4.44 | 5.26 | 48.48 | 46.97 | 8.20 | 9.26 | 0.9735 | 6.62 | 0.4548 | 14.61 | 23.08 | 5.18 | -10.62 | 6.20 | 19.06 | 0.00 |
| Bio-Rad Laboratories, Inc. | 2.30bn | 327.66m | 11.10bn | 8.26k | 35.06 | 2.16 | 24.03 | 4.82 | 10.55 | 12.19 | 76.82 | 171.41 | 0.3316 | 1.75 | 6.25 | 278,944.10 | 4.72 | 3.03 | 5.04 | 3.44 | 54.81 | 54.69 | 14.22 | 5.57 | 3.36 | -- | 0.0789 | 0.00 | 5.98 | 1.43 | 505.97 | 32.41 | 2.82 | -- |
| Allegion PLC | 2.84bn | 432.00m | 11.89bn | 11.00k | 28.06 | 17.38 | 23.08 | 4.19 | 4.56 | 4.79 | 29.94 | 7.36 | 1.01 | 5.60 | 7.78 | 257,900.00 | 15.46 | 11.44 | 18.75 | 14.50 | 43.48 | 43.01 | 15.24 | 11.35 | 1.30 | 10.04 | 0.675 | 19.54 | 13.43 | 5.71 | 26.84 | 62.99 | 19.44 | -- |
| Waters Corporation | 2.41bn | 568.89m | 15.31bn | 7.20k | 29.67 | 133.92 | 22.69 | 6.36 | 8.01 | 8.11 | 33.88 | 1.77 | 0.7284 | 2.93 | 4.84 | 334,072.40 | 17.23 | 11.88 | 20.47 | 13.59 | 58.49 | 58.95 | 23.65 | 23.68 | 1.63 | 40.21 | 0.9215 | 0.00 | 4.80 | 4.91 | 4.37 | 5.75 | 1.49 | -- |
| Keysight Technologies Inc | 4.30bn | 590.00m | 19.41bn | 13.60k | 33.31 | 6.43 | 21.61 | 4.51 | 3.09 | 3.25 | 22.56 | 16.02 | 0.6914 | 2.67 | 6.66 | 316,397.10 | 9.48 | 7.26 | 11.82 | 8.95 | 58.89 | 55.72 | 13.71 | 10.13 | 2.50 | 11.76 | 0.3731 | 0.00 | 10.96 | 7.97 | 276.36 | 9.64 | 11.38 | -- |
| Mettler-Toledo International Inc. | 2.98bn | 553.14m | 19.97bn | 16.00k | 37.39 | 45.56 | 31.17 | 6.70 | 21.93 | 21.79 | 118.36 | 18.00 | 1.15 | 4.52 | 5.98 | 186,412.90 | 21.30 | 18.42 | 29.29 | 25.79 | 57.68 | 56.77 | 18.55 | 15.63 | 0.9494 | 19.59 | 0.728 | 0.00 | 7.73 | 4.29 | 15.24 | 11.02 | 11.63 | -- |
| AMETEK, Inc. | 5.13bn | 840.24m | 22.76bn | 18.20k | 27.22 | 4.68 | 21.40 | 4.44 | 3.66 | 3.71 | 22.31 | 21.29 | 0.5915 | 5.38 | 6.59 | 281,596.90 | 9.70 | 8.63 | 11.02 | 10.09 | 34.67 | 36.25 | 16.39 | 14.50 | 1.48 | 13.55 | 0.333 | 15.16 | 12.69 | 6.16 | 29.88 | 8.18 | 5.33 | 18.47 |
| Fortive Corp | 6.33bn | 574.30m | 25.83bn | 24.00k | 45.47 | 3.61 | 26.92 | 4.08 | 1.69 | 7.65 | 18.66 | 21.30 | 0.415 | 4.66 | 4.82 | 263,895.80 | 4.22 | 9.71 | 5.34 | 11.72 | 51.03 | 49.79 | 10.16 | 13.98 | 0.955 | 6.06 | 0.4565 | 5.81 | 12.10 | 1.59 | 6.89 | 0.9332 | 6.73 | -- |
| Agilent Technologies Inc | 5.16bn | 1.07bn | 27.38bn | 16.30k | 26.28 | 5.74 | 20.91 | 5.30 | 3.36 | 3.36 | 16.25 | 15.37 | 0.5739 | 3.57 | 6.05 | 316,748.50 | 11.90 | 8.31 | 14.53 | 9.75 | 54.48 | 53.17 | 20.74 | 15.46 | 1.21 | 23.98 | 0.3364 | 24.13 | 5.07 | 4.99 | 23.39 | 35.79 | -5.32 | 4.43 |
| Emerson Electric Co. | 18.37bn | 2.21bn | 46.72bn | 88.00k | 21.55 | 5.69 | 15.32 | 2.54 | 3.56 | 3.72 | 29.60 | 13.47 | 0.8987 | 5.72 | 6.12 | 208,772.70 | 10.90 | 9.61 | 15.55 | 14.23 | 42.55 | 42.59 | 12.13 | 12.46 | 0.88 | 17.78 | 0.4088 | 61.30 | 5.54 | 0.7105 | 14.50 | 0.9364 | -1.82 | 2.65 |
| Illumina, Inc. | 3.46bn | 973.00m | 46.98bn | 7.30k | 49.07 | 10.58 | 41.17 | 13.59 | 6.51 | 6.51 | 23.13 | 30.20 | 0.4994 | 2.69 | 7.10 | 473,698.60 | 13.69 | 13.27 | 16.95 | 16.57 | 69.26 | 68.90 | 27.41 | 22.76 | 6.15 | -- | 0.203 | 0.00 | 21.11 | 18.59 | -4.45 | 46.20 | 26.73 | -- |
Data as of Jan 24 2020. Currency figures normalised to Illumina Inc's reporting currency: US Dollar USD
46.94%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Baillie Gifford & Co.as of 31 Dec 2019 | 17.74m | 12.07% |
| The Vanguard Group, Inc.as of 30 Sep 2019 | 11.17m | 7.60% |
| Capital Research & Management Co. (Global Investors)as of 30 Sep 2019 | 7.91m | 5.38% |
| BlackRock Fund Advisorsas of 30 Sep 2019 | 7.87m | 5.35% |
| SSgA Funds Management, Inc.as of 30 Sep 2019 | 6.03m | 4.11% |
| Jennison Associates LLCas of 30 Sep 2019 | 4.84m | 3.29% |
| Edgewood Management LLCas of 30 Sep 2019 | 4.78m | 3.25% |
| Sands Capital Management LLCas of 30 Sep 2019 | 3.53m | 2.40% |
| Morgan Stanley Investment Management, Inc.as of 30 Sep 2019 | 2.81m | 1.92% |
| Geode Capital Management LLCas of 30 Sep 2019 | 2.32m | 1.58% |
More ▼
Data from 30 Sep 2019 - 30 Sep 2019Source: FactSet Research Systems Inc.
